Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin in Advanced Uterine Leiomyosarcoma
NCT00379145Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Jun 2007
- Primary completion
- Jan 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in uterine leiomyosarcoma (uLMS), sponsored by GOG Foundation. Started Jun 2007; status: completed.
02
Drugs
trabectedin
03
Conditions
uterine leiomyosarcoma (uLMS)
Beyond the preview
Go deeper on NCT00379145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00379145.